[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Antibacterial Drugs Market Report 2017

January 2017 | 115 pages | ID: UC927215453EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Antibacterial Drugs

Revenue, means the sales value of Antibacterial Drugs

This report studies sales (consumption) of Antibacterial Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Pfizer
  • Merck & Co.
  • GlaxoSmithKline
  • Novartis
  • Bayer
  • Taisho Pharmaceuticals
  • AstraZeneca
  • Abbott Labs
  • Daiichi Sankyo
  • Johnson & Johnson
  • Eli Lilly and Company
  • Sanofi SA
  • Bristol-Myers Squibb Company
  • Forest Laboratories
Market Segment by States, covering
  • California
  • Texas
  • New York
  • Florida
  • Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Cephalosporins
  • Penicillins
  • Fluoroquinolones
  • Macrolides
  • Carbapenems
  • Other antibiotics
Split by applications, this report focuses on sales, market share and growth rate of Antibacterial Drugs in each application, can be divided into
  • Hospitals
  • Clinics
  • Others
United States Antibacterial Drugs Market Report 2017

1 ANTIBACTERIAL DRUGS OVERVIEW

1.1 Product Overview and Scope of Antibacterial Drugs
1.2 Classification of Antibacterial Drugs
  1.2.1 Cephalosporins
  1.2.2 Penicillins
  1.2.3 Fluoroquinolones
  1.2.4 Macrolides
  1.2.5 Carbapenems
  1.2.6 Other antibiotics
1.3 Application of Antibacterial Drugs
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Antibacterial Drugs (2011-2021)
  1.4.1 United States Antibacterial Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Antibacterial Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES ANTIBACTERIAL DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Antibacterial Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Antibacterial Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Antibacterial Drugs Average Price by Manufactures (2015 and 2016)
2.4 Antibacterial Drugs Market Competitive Situation and Trends
  2.4.1 Antibacterial Drugs Market Concentration Rate
  2.4.2 Antibacterial Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ANTIBACTERIAL DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Antibacterial Drugs Sales and Market Share by States (2011-2016)
3.2 United States Antibacterial Drugs Revenue and Market Share by States (2011-2016)
3.3 United States Antibacterial Drugs Price by States (2011-2016)

4 UNITED STATES ANTIBACTERIAL DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Antibacterial Drugs Sales and Market Share by Type (2011-2016)
4.2 United States Antibacterial Drugs Revenue and Market Share by Type (2011-2016)
4.3 United States Antibacterial Drugs Price by Type (2011-2016)
4.4 United States Antibacterial Drugs Sales Growth Rate by Type (2011-2016)

5 UNITED STATES ANTIBACTERIAL DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Antibacterial Drugs Sales and Market Share by Application (2011-2016)
5.2 United States Antibacterial Drugs Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTIBACTERIAL DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antibacterial Drugs Product Type, Application and Specification
    6.1.2.1 Cephalosporins
    6.1.2.2 Penicillins
  6.1.3 Pfizer Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Merck & Co.
  6.2.2 Antibacterial Drugs Product Type, Application and Specification
    6.2.2.1 Cephalosporins
    6.2.2.2 Penicillins
  6.2.3 Merck & Co. Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline
  6.3.2 Antibacterial Drugs Product Type, Application and Specification
    6.3.2.1 Cephalosporins
    6.3.2.2 Penicillins
  6.3.3 GlaxoSmithKline Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Novartis
  6.4.2 Antibacterial Drugs Product Type, Application and Specification
    6.4.2.1 Cephalosporins
    6.4.2.2 Penicillins
  6.4.3 Novartis Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Bayer
  6.5.2 Antibacterial Drugs Product Type, Application and Specification
    6.5.2.1 Cephalosporins
    6.5.2.2 Penicillins
  6.5.3 Bayer Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Taisho Pharmaceuticals
  6.6.2 Antibacterial Drugs Product Type, Application and Specification
    6.6.2.1 Cephalosporins
    6.6.2.2 Penicillins
  6.6.3 Taisho Pharmaceuticals Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 AstraZeneca
  6.7.2 Antibacterial Drugs Product Type, Application and Specification
    6.7.2.1 Cephalosporins
    6.7.2.2 Penicillins
  6.7.3 AstraZeneca Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Abbott Labs
  6.8.2 Antibacterial Drugs Product Type, Application and Specification
    6.8.2.1 Cephalosporins
    6.8.2.2 Penicillins
  6.8.3 Abbott Labs Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Daiichi Sankyo
  6.9.2 Antibacterial Drugs Product Type, Application and Specification
    6.9.2.1 Cephalosporins
    6.9.2.2 Penicillins
  6.9.3 Daiichi Sankyo Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Johnson & Johnson
  6.10.2 Antibacterial Drugs Product Type, Application and Specification
    6.10.2.1 Cephalosporins
    6.10.2.2 Penicillins
  6.10.3 Johnson & Johnson Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Eli Lilly and Company
6.12 Sanofi SA
6.13 Bristol-Myers Squibb Company
6.14 Forest Laboratories

7 ANTIBACTERIAL DRUGS MANUFACTURING COST ANALYSIS

7.1 Antibacterial Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antibacterial Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antibacterial Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antibacterial Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTIBACTERIAL DRUGS MARKET FORECAST (2016-2021)

11.1 United States Antibacterial Drugs Sales, Revenue Forecast (2016-2021)
11.2 United States Antibacterial Drugs Sales Forecast by Type (2016-2021)
11.3 United States Antibacterial Drugs Sales Forecast by Application (2016-2021)
11.4 Antibacterial Drugs Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Antibacterial Drugs
Table Classification of Antibacterial Drugs
Figure United States Sales Market Share of Antibacterial Drugs by Type in 2015
Figure Cephalosporins Picture
Figure Penicillins Picture
Figure Fluoroquinolones Picture
Figure Macrolides Picture
Figure Carbapenems Picture
Figure Other antibiotics Picture
Table Application of Antibacterial Drugs
Figure United States Sales Market Share of Antibacterial Drugs by Application in 2015
Figure Hospitals Examples
Figure Clinics Examples
Figure Others Examples
Figure United States Antibacterial Drugs Sales and Growth Rate (2011-2021)
Figure United States Antibacterial Drugs Revenue and Growth Rate (2011-2021)
Table United States Antibacterial Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Antibacterial Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antibacterial Drugs Sales Share by Manufacturers
Figure 2016 Antibacterial Drugs Sales Share by Manufacturers
Table United States Antibacterial Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Antibacterial Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Antibacterial Drugs Revenue Share by Manufacturers
Table 2016 United States Antibacterial Drugs Revenue Share by Manufacturers
Table United States Market Antibacterial Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Antibacterial Drugs Average Price of Key Manufacturers in 2015
Figure Antibacterial Drugs Market Share of Top 3 Manufacturers
Figure Antibacterial Drugs Market Share of Top 5 Manufacturers
Table United States Antibacterial Drugs Sales by States (2011-2016)
Table United States Antibacterial Drugs Sales Share by States (2011-2016)
Figure United States Antibacterial Drugs Sales Market Share by States in 2015
Table United States Antibacterial Drugs Revenue and Market Share by States (2011-2016)
Table United States Antibacterial Drugs Revenue Share by States (2011-2016)
Figure Revenue Market Share of Antibacterial Drugs by States (2011-2016)
Table United States Antibacterial Drugs Price by States (2011-2016)
Table United States Antibacterial Drugs Sales by Type (2011-2016)
Table United States Antibacterial Drugs Sales Share by Type (2011-2016)
Figure United States Antibacterial Drugs Sales Market Share by Type in 2015
Table United States Antibacterial Drugs Revenue and Market Share by Type (2011-2016)
Table United States Antibacterial Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Antibacterial Drugs by Type (2011-2016)
Table United States Antibacterial Drugs Price by Type (2011-2016)
Figure United States Antibacterial Drugs Sales Growth Rate by Type (2011-2016)
Table United States Antibacterial Drugs Sales by Application (2011-2016)
Table United States Antibacterial Drugs Sales Market Share by Application (2011-2016)
Figure United States Antibacterial Drugs Sales Market Share by Application in 2015
Table United States Antibacterial Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Antibacterial Drugs Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Antibacterial Drugs Sales Market Share (2011-2016)
Table Merck & Co. Basic Information List
Table Merck & Co. Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Antibacterial Drugs Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Antibacterial Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Antibacterial Drugs Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Antibacterial Drugs Sales Market Share (2011-2016)
Table Taisho Pharmaceuticals Basic Information List
Table Taisho Pharmaceuticals Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Taisho Pharmaceuticals Antibacterial Drugs Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Antibacterial Drugs Sales Market Share (2011-2016)
Table Abbott Labs Basic Information List
Table Abbott Labs Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Labs Antibacterial Drugs Sales Market Share (2011-2016)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daiichi Sankyo Antibacterial Drugs Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Antibacterial Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Antibacterial Drugs Sales Market Share (2011-2016)
Table Eli Lilly and Company Basic Information List
Table Sanofi SA Basic Information List
Table Bristol-Myers Squibb Company Basic Information List
Table Forest Laboratories Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibacterial Drugs
Figure Manufacturing Process Analysis of Antibacterial Drugs
Figure Antibacterial Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antibacterial Drugs Major Manufacturers in 2015
Table Major Buyers of Antibacterial Drugs
Table Distributors/Traders List
Figure United States Antibacterial Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Antibacterial Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Antibacterial Drugs Production Forecast by Type (2016-2021)
Table United States Antibacterial Drugs Consumption Forecast by Application (2016-2021)
Table United States Antibacterial Drugs Sales Forecast by States (2016-2021)
Table United States Antibacterial Drugs Sales Share Forecast by States (2016-2021)


More Publications